Compile Data Set for Download or QSAR
Report error Found 115 Enz. Inhib. hit(s) with all data for entry = 11314
TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606220(US11685719, Example 8A | US11685719, Example 8B)
Affinity DataIC50: 0.794nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606215(US11685719, Example 5A | US11685719, Example 5B | ...)
Affinity DataIC50: 1nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606246(US11685719, Example 20A | US11685719, Example 20B)
Affinity DataIC50: 1nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606262(US11685719, Example 28A | US11685719, Example 28B)
Affinity DataIC50: 1nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606218(US11685719, Example 7A | US11685719, Example 23A |...)
Affinity DataIC50: 1nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606233(US11685719, Example 14B | US11685719, Example 14D)
Affinity DataIC50: 1.26nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606213(US11685719, Example 4A | US11685719, Example 21A |...)
Affinity DataIC50: 1.26nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606240(US11685719, Example 17A | US11685719, Example 17B)
Affinity DataIC50: 1.58nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606232(US11685719, Example 14A | US11685719, Example 14C)
Affinity DataIC50: 1.58nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606207(US11685719, Example 1A | US11685719, Example 1B | ...)
Affinity DataIC50: 1.58nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606213(US11685719, Example 4A | US11685719, Example 21A |...)
Affinity DataIC50: 2nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606207(US11685719, Example 1A | US11685719, Example 1B | ...)
Affinity DataIC50: 2nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606250(US11685719, Example 22A | US11685719, Example 22B ...)
Affinity DataIC50: 2nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606218(US11685719, Example 7A | US11685719, Example 23A |...)
Affinity DataIC50: 2.51nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606215(US11685719, Example 5A | US11685719, Example 5B | ...)
Affinity DataIC50: 2.51nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606250(US11685719, Example 22A | US11685719, Example 22B ...)
Affinity DataIC50: 2.51nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606258(US11685719, Example 26A | US11685719, Example 26B)
Affinity DataIC50: 2.51nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606207(US11685719, Example 1A | US11685719, Example 1B | ...)
Affinity DataIC50: 3.16nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606209(US11685719, Example 2A | US11685719, Example 2B)
Affinity DataIC50: 3.98nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606256(US11685719, Example 25A | US11685719, Example 25B)
Affinity DataIC50: 3.98nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606226(US11685719, Example 11A | US11685719, Example 11B)
Affinity DataIC50: 3.98nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606211(US11685719, Example 3A | US11685719, Example 3B)
Affinity DataIC50: 6.31nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606236(US11685719, Example 15A | US11685719, Example 15B)
Affinity DataIC50: 10nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606260(US11685719, Example 27A | US11685719, Example 27B)
Affinity DataIC50: 12.6nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606228(US11685719, Example 12A | US11685719, Example 12B)
Affinity DataIC50: 12.6nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606222(US11685719, Example 9A | US11685719, Example 9B)
Affinity DataIC50: 12.6nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606217(US11685719, Example 6)
Affinity DataIC50: 20nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606218(US11685719, Example 7A | US11685719, Example 23A |...)
Affinity DataIC50: 100nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606260(US11685719, Example 27A | US11685719, Example 27B)
Affinity DataIC50: 100nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606262(US11685719, Example 28A | US11685719, Example 28B)
Affinity DataIC50: 100nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606224(US11685719, Example 10A | US11685719, Example 10B)
Affinity DataIC50: 100nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606207(US11685719, Example 1A | US11685719, Example 1B | ...)
Affinity DataIC50: 100nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606258(US11685719, Example 26A | US11685719, Example 26B)
Affinity DataIC50: 100nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606250(US11685719, Example 22A | US11685719, Example 22B ...)
Affinity DataIC50: 100nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606238(US11685719, Example 16A | US11685719, Example 16B)
Affinity DataIC50: 200nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606246(US11685719, Example 20A | US11685719, Example 20B)
Affinity DataIC50: 316nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606207(US11685719, Example 1A | US11685719, Example 1B | ...)
Affinity DataIC50: 398nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606256(US11685719, Example 25A | US11685719, Example 25B)
Affinity DataIC50: 631nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606215(US11685719, Example 5A | US11685719, Example 5B | ...)
Affinity DataIC50: 794nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

LigandPNGBDBM606260(US11685719, Example 27A | US11685719, Example 27B)
Affinity DataIC50: 794nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606220(US11685719, Example 8A | US11685719, Example 8B)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606236(US11685719, Example 15A | US11685719, Example 15B)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606222(US11685719, Example 9A | US11685719, Example 9B)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606238(US11685719, Example 16A | US11685719, Example 16B)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606250(US11685719, Example 22A | US11685719, Example 22B ...)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606224(US11685719, Example 10A | US11685719, Example 10B)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606240(US11685719, Example 17A | US11685719, Example 17B)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606226(US11685719, Example 11A | US11685719, Example 11B)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606209(US11685719, Example 2A | US11685719, Example 2B)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetMitogen-activated protein kinase 14/1(Human)
Xinthera

US Patent
LigandPNGBDBM606228(US11685719, Example 12A | US11685719, Example 12B)
Affinity DataIC50: 1.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

Displayed 1 to 50 (of 115 total ) | Next | Last >>
Jump to: